Publications by authors named "S Negoita"
Childhood cancers are a heterogeneous group of rare diseases, accounting for less than 2% of all cancers diagnosed worldwide. Most countries, therefore, do not have enough cases to provide robust information on epidemiology, treatment, and late effects, especially for rarer types of cancer. Thus, only through a concerted effort to share data internationally will we be able to answer research questions that could not otherwise be answered.
View Article and Find Full Text PDFBackground: To assess proportions of metastatic recurrence in women initially diagnosed with non-metastatic breast cancer by stage at diagnosis, breast cancer subtype, calendar period and age.
Methods: A systematic search of MEDLINE and Web of Science databases (January 2010-12 May 2022) was conducted. Studies reporting the proportion of distant metastatic recurrence in women with non-metastatic breast cancer were identified and outcomes and characteristics were extracted.
Article Synopsis
- The study investigates how well population-based registries track long-term outcomes, especially metastatic recurrence, in women treated for nonmetastatic breast cancer.
- It reviews 23 studies from 11 registries across 8 countries, finding that most data on recurrence are collected inconsistently and primarily for specific research projects rather than as part of standard procedures.
- The authors conclude that cancer registries should enhance their data collection processes to include recurrence information, which is essential for understanding the prognosis of breast cancer survivors.
Background: In 2018, Romania established national guidelines for patient blood management (PBM), endorsed by the Romanian Society of Anesthesia and Intensive Care (SRATI) and approved by the Ministry of Health. These guidelines emphasize managing anemia, coagulation issues, and the cautious use of allogeneic transfusions to improve patient outcomes.
Materials And Methods: A national survey was conducted among Romanian anesthesiologists to assess PBM guideline adoption.
Article Synopsis
- - The COVID-19 pandemic caused a significant drop in cancer diagnosis rates in 2020 due to disruptions in screening and diagnostic services.
- - A study using 2021 data showed that while overall cancer incidence rates were close to pre-pandemic levels, they didn't fully recover from the missed diagnoses of 2020.
- - Some cancers, like metastatic breast cancer, were notably higher in observed rates than expected, indicating a need for ongoing monitoring and specific actions to manage the long-term effects of the pandemic on cancer care.